Berinert 500 IU inf. sol. (pwdr. + solv.) i.v. vial Belgien - engelska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

berinert 500 iu inf. sol. (pwdr. + solv.) i.v. vial

csl behring gmbh - c1 esterase inhibitor, human 400 iu - 625 iu - powder and solvent for solution for infusion - 500 iu - c1 esterase inhibitor - c1-inhibitor, plasma derived

Berinert 1 500 IU inj. sol. (pwdr. + solv.) i.v. vial Belgien - engelska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

berinert 1 500 iu inj. sol. (pwdr. + solv.) i.v. vial

csl behring gmbh - c1 esterase inhibitor, human 1200 iu - 1875 iu eq. proteins total - eq. proteins total 150 mg - 240 mg - powder and solvent for solution for injection - 1500 iu - c1 esterase inhibitor - c1-inhibitor, plasma derived

Berinert 3 000 IU inj. sol. (pwdr. + solv.) s.c. vial Belgien - engelska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

berinert 3 000 iu inj. sol. (pwdr. + solv.) s.c. vial

csl behring gmbh - c1 esterase inhibitor, human 3000 iu - eq. proteins total 390 mg - powder and solvent for solution for injection - 3000 iu - c1 esterase inhibitor 3000 iu - c1-inhibitor, plasma derived

Berinert  2 000 IU inj. sol. (pwdr. + solv.) s.c. vial Belgien - engelska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

berinert 2 000 iu inj. sol. (pwdr. + solv.) s.c. vial

csl behring gmbh - c1 esterase inhibitor, human 2000 iu - eq. proteins total 260 mg - powder and solvent for solution for injection - 2000 iu - c1 esterase inhibitor 2000 iu - c1-inhibitor, plasma derived

Cinryze Europeiska unionen - engelska - EMA (European Medicines Agency)

cinryze

takeda manufacturing austria ag - c1 inhibitor (human) - angioedemas, hereditary - c1-inhibitor, plasma derived, drugs used in hereditary angioedema - treatment and pre-procedure prevention of angioedema attacks in adults, adolescents and children (2 years old and above) with hereditary angioedema (hae).routine prevention of angioedema attacks in adults, adolescents and children (6 years old and above) with severe and recurrent attacks of hereditary angioedema (hae), who are intolerant to or insufficiently protected by oral prevention treatments, or patients who are inadequately managed with repeated acute treatment.

Berinert 3000IU Powder and solvent for solution for injection Malta - engelska - Malta Medicines Authority

berinert 3000iu powder and solvent for solution for injection

csl behring gmbh emil-von-behring-strasse 76, 35041 marburg, germany - c, esterase inhibitor, human - powder and solvent for solution for injection - c1-esterase inhibitor, human 3000 iu - other hematological agents

Berinert 2000IU Powder and solvent for solution for injection Malta - engelska - Malta Medicines Authority

berinert 2000iu powder and solvent for solution for injection

csl behring gmbh emil-von-behring-strasse 76, 35041 marburg, germany - c, esterase inhibitor, human - powder and solvent for solution for injection - c1-esterase inhibitor, human 2000 iu - other hematological agents

Berinert 500IU Powder and solvent for solution for injection /infusion Malta - engelska - Malta Medicines Authority

berinert 500iu powder and solvent for solution for injection /infusion

csl behring gmbh emil-von-behring-strasse 76, 35041 marburg, germany - c, esterase inhibitor, human - powder and solvent for solution for infusion or injection - c1-esterase inhibitor, human 500 iu - other hematological agents

Berinert 1500IU Powder and solvent for solution for injection /infusion Malta - engelska - Malta Medicines Authority

berinert 1500iu powder and solvent for solution for injection /infusion

csl behring gmbh emil-von-behring-strasse 76, 35041 marburg, germany - c, esterase inhibitor, human - powder and solvent for solution for injection - c1-esterase inhibitor, human 1500 iu - other hematological agents

BERINERT Israel - engelska - Ministry of Health

berinert

csl behring ltd., israel - c - 1 esterase inhibitor human - powder for solution for inj/inf - c - 1 esterase inhibitor human 500 iu/vial - c1- inhibitor,plasma derived - c1- inhibitor,plasma derived - hereditary angioedema type i and ii (hae).treatment and pre-procedure (prior to oral, dental, and upper respiratory tract procedures) prevention of acute episodes